The regulation of the expression of the Escherichia coli metF gene, which codes for 5,10-methylenetetrahydrofolate reductase (EC 1.1.99.15), has been investigated by using a simplified DNA-directed in vitro system that measures the formation of the first dipeptide (fMet-Ser) of the gene product. The synthesis of fMet-Ser directed by a plasmid containing the metF gene is specifically inhibited by metJ protein (repressor protein). S-Adenosylmethionine enhances the inhibition by the metJ protein of metF gene expression. The inhibition by the metJ protein is at the level of transcription and the results suggest that S-adenosylmethionine is functioning as an allosteric effector.
The genes required for methionine synthesis in Escherichia coli are scattered throughout the chromosome (1), yet the synthesis of the proteins coded for by these genes is coordinately controlled by the level of methionine in the growth medium (2) (3) (4) (5) (6) . Genetic and biochemical studies have indicated that the metJ gene product is a regulatory protein that is required for methionine repression of the methionine regulon (7) (8) (9) . Since metK mutants, which are deficient in S-adenosylmethionine (AdoMet) synthetase (EC 2.5.1.6), also are regulatory mutants (10, 11) , it appears that AdoMet, and not methionine, functions with the metJ gene product (repressor protein) to repress the methionine regulon. In addition, a second mechanism exists that specifically affects the expression of the metF (5,10-methylenetetrahydrofolate reductase, EC 1.1.99. 15) , and the metE (non-B12 N5-methyltetrahydrofolate:homocysteine S-methyltransferase, EC 2.1.1.14) genes. Milner et al. (12) demonstrated that the synthesis of the metE and metF gene products in E. coli was repressed by the addition of vitamin B12 to the growth medium. The results were consistent with a mechanism in which the metH gene product (B12-dependent methyltransferase, EC 2.1.1.13), which contains a cobalamin prosthetic group, was the functional repressor. The specificity of the vitamin B12 repression in these studies (only the metE and metF gene products were affected) indicated that the vitamin was not functioning by simply increasing the level of methionine in the cell due to activation of the B12-dependent methyltransferase (12) . Although the methionine and vitamin B12 repressions appear to involve different mechanisms, there are some data to suggest that the metJ protein is also involved in the vitamin B12 effect on the expression of the metF gene but not the metE gene (9) . A summary of some of these reactions, including where methionine and vitamin B12 play a regulatory role, is shown in Fig. 1 .
Recently, the metF gene has been cloned and sequenced (13) . In the present report, we have used a plasmid containing S-Adenosylmethionine FIG. 1. Terminal reactions in methionine biosynthesis. Letters in parentheses refer to the genes that code for the different enzymes. F, 5,10-methylenetetrahydrofolate reductase; E, non-B12 methyltransferase; H, B12-dependent methyltransferase; K, AdoMet synthetase. The genes whose expression is regulated by growth in the presence of methionine (Met) and vitamin B12 (B12) are indicated. the metF gene as template for in vitro studies on the regulation of the expression of this gene. fMet-tRNAfmel was prepared as previously described (15, 16) . The specific activities of the H-aminoacylated tRNAs were 2500-4600 cpm/pmol. AdoMet was obtained from Sigma and was purified by ion-exchange chromatography on Dowex 1 HCO- (17) .
MATERIALS AND METHODS

Materials. L-
Plasmid pNF1337 (18) , containing the ribosomal protein L10 operon, was originally supplied by J. Friesen (University of Toronto). Plasmid pRCG161, containing the metF gene, was constructed from the transducing phage X dmetl4l (19) . This phage carries a functional copy of the metF gene and a portion of the metL gene but lacks the metJ and metB genes. EcoRI/Pst I double digests of X dmetl4l DNA and pBR322
Abbreviations: AdoMet, S-adenosylmethionine; EF-G, elongation factor G.
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DNA were ligated with T4 DNA ligase. The The preparation and characterization of the purified metJ gene product will be described elsewhere. The (20) .
DNA-and mRNA-Directed Dipeptide and Tripeptide Synthesis. The in vitro systems for DNA-and RNA-directed dipeptide and tripeptide synthesis have been previously described (21) (22) (23) (24) (25) (21) .
For dipeptide synthesis, the second amino acid was labeled with tritium and acylated to the appropriate isoacceptor tRNA species. For tripeptide synthesis, the appropriate unlabeled second aminoacyl-tRNA was used and the third 3H-aminoacyl-tRNA and elongation factor G (EF-G) were added (22, 24) . Unless otherwise indicated, metJ protein (0. 4 ,ug/35-,ul reaction mixture) and AdoMet (50 ,tM) were added at the beginning of the incubation.
The assay for the synthesis of the dipeptide and tripeptide products by using cation-exchange chromatography is described elsewhere (25) .
DNA-Directed Protein Synthesis in Vitro. A highly defined E. coli DNA-directed in vitro protein synthesis system (26, 27) was also used for some of these studies. Each incubation mixture contained either 0.5 ,ug of pBR322 DNA or 1 ,g of pRCG161 as template and the reaction was carried out for 60 min at 37°C. Radioactive material precipitable by hot C13CCOOH was measured and aliquots of the incubation mixtures were applied to NaDodSO4/15% polyacrylamide gels (28) . After electrophoresis, the gels were soaked in EN3HANCE (New England Nuclear), dried, and fluorographed at -70°C.
RESULTS
In Vitro Expression of the First Dipeptide of the metF Gene Product. Plasmid pRCG161 was used as template in a simplified system that has been developed to measure the first di-or tripeptide of a gene product. The DNA sequence of the NH2-terminal coding region of the metF gene is AUG-AGC-TTT (13) , which corresponds to an initial tripeptide of (f)Met-Ser-Phe. Fig. 2 replace Ser-tRNAser in dipeptide formation and an unrelated species, Ala-tRNAla, was also inactive. Tripeptide synthesis was used to further substantiate that the metF gene was being expressed from pRCG161. As seen in Table 2 , significant formation of fMet-Ser-Phe is obtained that is dependent on both EF-G and Ser-tRNAscr. Because of the simplicity of the dipeptide system, it was used initially to study the regulation of the expression of the metF gene product.
Effect of the metF Gene Product and AdoMet on Expression of the metF Gene. Genetic and biochemical studies have indicated that the metJ gene product and AdoMet are involved in the repression of the methionine biosynthetic pathway (7) (8) (9) (10) (11) . Therefore, the purified metJ gene product and AdoMet were tested in the dipeptide system for their effect on the expression of the metF gene from plasmid pRCG161, the 84-lactamase gene from plasmid pBR322, and the ribosomal protein L10 and L12 genes from plasmid pNF1337. AdoMet alone, at concentrations up to 100 ,M, had no effect on dipeptide synthesis (data not shown). The metJ protein, in the presence of AdoMet, inhibited metF gene expression (Fig. 3A) but had no significant effect on Plactamase expression or on the expression ofthe L10 and L12 genes (data not shown). In all of these experiments, AdoMet was present at a concentration of 50 ,M but, as shown in Fig.  3A , the requirement for AdoMet is dependent on the amount of metJ protein present. At low concentrations (<0.5 ,ug per incubation) of the metJ protein, the addition of AdoMet markedly increases the inhibitory effect of the metJ protein.
However, higher levels of the metJ protein alone (>1.5 jig per incubation) can significantly inhibit fMet-Ser formation directed by pRCG161. The ability of AdoMet to enhance the effect of low levels of the metJ protein on metF gene expression was dependent on the concentration of AdoMet (Fig. 3B) . Concentrations of AdoMet above 10 ,uM were required to obtain a significant effect, and S-adenosylhomocysteine (50 ALM) could not replace AdoMet in this system, nor did it inhibit the AdoMet-mediated action of the metJ protein (data not shown). It should be noted that different preparations ofthe metJ protein all gave similar results in that high concentrations of the protein inhibited metF expression in the absence of AdoMet, whereas lower amounts of metJ protein required AdoMet for maximal inhibition. However, each batch of metJ protein had to be titrated separately to obtain the level that gave the optimal stimulation by AdoMet.
Initial experiments performed at various Mg2" concentrations yielded variable results, suggesting that the effect of the metJ protein and AdoMet on fMet-Ser formation directed by pRCG161 was also dependent on the concentration of Mg2+. As seen in Fig. 4 , at Mg2+ concentrations above 13 mM the metJ protein has little effect on dipeptide synthesis. Routinely, the incubation mixtures for dipeptide synthesis contained between 9 and 10.5 mM Mg2+, which appears optimal for both dipeptide synthesis and the metJ protein inhibitory effect. Effect of the med Gene Product on Transcription. As seen in Table 3 , the metJ protein inhibited the expression of the metF gene from the plasmid template but not from the mRNA prepared from that plasmid (see Materials and Methods). These results indicate that the metJ protein is affecting transcription ofthe metFgene, or specifically inactivating the DNA template. To test for a specific nuclease activity associated with the metJ protein, aliquots of plasmid pRCG161 DNA were incubated in the dipeptide system in the presence and absence of metJ protein and were subjected to Fig. 5 shows a gel of the products labeled with [35S]methionine in vitro, using either pBR322 or pRCG161 as template. With the former template, the major product in vitro is ,-lactamase, molecular weight -32,000 (lane 3) , whereas with the metF plasmid, a protein that migrates with an apparent molecular weight of -31,000 is synthesized (lane 5). The latter is in reasonable agreement with the calculated molecular weight of 33,000 for the metF gene product (13) . As also seen in Fig. 5 , addition of metJ protein and AdoMet markedly inhibits the synthesis of the metF protein (lane 6) but has no effect on the synthesis of /8-lactamase (lane 4).
DISCUSSION
There appear to be two distinct mechanisms that are involved in the regulation of the methionine biosynthetic pathway in E. coli. With the exception of the B12-dependent methyltransferase (metHgene product), all of the genes in this regulon are repressed by the presence of methionine in the growth lack of a complete dependency on AdoMet as well as the variation in the activity of the metJ protein could be explained if each preparation of the metJ protein varied in the extent of methylation. Preliminary attempts to show a transfer of a methyl group from AdoMet to the metJ protein or the plasmid DNA have been unsuccessful. The fact that S-adenosylhomocysteine, known to be an inhibitor of AdoMetdependent methyltransferases (29) , had no effect in this system provides additional indirect evidence that the metJ protein is not functioning simply as a methyltransferase. Another possibility is that a AdoMet-metJ protein complex is the active repressor and that the different metJ preparations may contain various amounts of tightly bound AdoMet. However, a stable binding of AdoMet to the metJ protein could not be demonstrated and the A28o/A260 ratio of the purified protein was 1.7, which argues against the presence of AdoMet bound to the protein. At present, the results favor the view that AdoMet is acting as an allosteric effector for the metJ protein. The plot of inhibition as a function of AdoMet concentration showed a sigmoidal curve (Fig. 3B) , which would be consistent with an allosteric mechanism. It is clear that further information is needed on the structure of the purified metJ protein and its ability to interact with the metF regulatory region to elucidate how AdoMet is functioning in this system. medium (2-6, 9, 12) . There are two known classes of regulatory mutants of methionine biosynthesis, referred to as metJ and metK mutants (7) (8) (9) (10) (11) . Since the metK gene product is responsible for the synthesis of AdoMet (7, 9) , one could picture the metJ gene product as either a repressor protein that requires AdoMet for activity or a methyltransferase that accepts or transfers a methyl group from AdoMet.
The availability of a cloned metF gene and purified metJ protein has enabled us to investigate the in vitro expression and regulation of the metF gene. For these studies, we primarily have used a simplified in vitro system that measures the formation of the first dipeptide of the gene product, although these results have also been confirmed in a defined in vitro system that is capable of synthesizing the entire gene product. A specific inhibition by the metJ protein and AdoMet on the expression of the metF gene has been observed. Although high levels of the metJ protein alone can inhibit metF gene expression, AdoMet markedly stimulated the inhibition when low levels of the metJ protein were used. The inhibition observed was at the level of transcription, supporting the view that the metJ protein is a repressor. However, the role of AdoMet in this process is still not clear. As noted above, the ability of AdoMet to enhance the metJ protein effect was greatest at low metJ protein concentrations, but it did vary with different preparations of the metJ protein. For example, one batch of metJ protein showed significant inhibition of metF gene expression even when added at low levels (<0.5 ,ug per incubation), and AdoMet caused only a 2-fold enhancement of the effect. Other preparations of metJ protein showed essentially no effect when present at low levels unless AdoMet was present (see Fig. 3A ). One explanation for these results might be that the isolated metJ protein is a mixture that consists of a methylated (active) and nonmethylated (inactive) species. If so, the
